777 related articles for article (PubMed ID: 27342212)
1. Loss of Junctional Adhesion Molecule A Promotes Severe Steatohepatitis in Mice on a Diet High in Saturated Fat, Fructose, and Cholesterol.
Rahman K; Desai C; Iyer SS; Thorn NE; Kumar P; Liu Y; Smith T; Neish AS; Li H; Tan S; Wu P; Liu X; Yu Y; Farris AB; Nusrat A; Parkos CA; Anania FA
Gastroenterology; 2016 Oct; 151(4):733-746.e12. PubMed ID: 27342212
[TBL] [Abstract][Full Text] [Related]
2. Blocking integrin α
Rai RP; Liu Y; Iyer SS; Liu S; Gupta B; Desai C; Kumar P; Smith T; Singhi AD; Nusrat A; Parkos CA; Monga SP; Czaja MJ; Anania FA; Raeman R
J Hepatol; 2020 Nov; 73(5):1013-1022. PubMed ID: 32540177
[TBL] [Abstract][Full Text] [Related]
3. Western diet-induced increase in colonic bile acids compromises epithelial barrier in nonalcoholic steatohepatitis.
Gupta B; Liu Y; Chopyk DM; Rai RP; Desai C; Kumar P; Farris AB; Nusrat A; Parkos CA; Anania FA; Raeman R
FASEB J; 2020 May; 34(5):7089-7102. PubMed ID: 32275114
[TBL] [Abstract][Full Text] [Related]
4. Microbiota-driven gut vascular barrier disruption is a prerequisite for non-alcoholic steatohepatitis development.
Mouries J; Brescia P; Silvestri A; Spadoni I; Sorribas M; Wiest R; Mileti E; Galbiati M; Invernizzi P; Adorini L; Penna G; Rescigno M
J Hepatol; 2019 Dec; 71(6):1216-1228. PubMed ID: 31419514
[TBL] [Abstract][Full Text] [Related]
5. Characterization of a murine nonalcoholic steatohepatitis model induced by high fat high calorie diet plus fructose and glucose in drinking water.
Liu XJ; Duan NN; Liu C; Niu C; Liu XP; Wu J
Lab Invest; 2018 Sep; 98(9):1184-1199. PubMed ID: 29959418
[TBL] [Abstract][Full Text] [Related]
6. The FATZO mouse, a next generation model of type 2 diabetes, develops NAFLD and NASH when fed a Western diet supplemented with fructose.
Sun G; Jackson CV; Zimmerman K; Zhang LK; Finnearty CM; Sandusky GE; Zhang G; Peterson RG; Wang YJ
BMC Gastroenterol; 2019 Mar; 19(1):41. PubMed ID: 30885145
[TBL] [Abstract][Full Text] [Related]
7. Gut inflammation exacerbates hepatic injury in the high-fat diet induced NAFLD mouse: Attention to the gut-vascular barrier dysfunction.
Cheng C; Tan J; Qian W; Zhang L; Hou X
Life Sci; 2018 Sep; 209():157-166. PubMed ID: 30096384
[TBL] [Abstract][Full Text] [Related]
8. Overactivation of intestinal sterol response element-binding protein 2 promotes diet-induced nonalcoholic steatohepatitis.
Malhotra P; Aloman C; Ankireddy A; Khadra H; Ooka K; Gill RK; Saksena S; Dudeja PK; Alrefai WA
Am J Physiol Gastrointest Liver Physiol; 2017 Nov; 313(5):G376-G385. PubMed ID: 28774869
[TBL] [Abstract][Full Text] [Related]
9. High-fat, high-fructose, high-cholesterol feeding causes severe NASH and cecal microbiota dysbiosis in juvenile Ossabaw swine.
Panasevich MR; Meers GM; Linden MA; Booth FW; Perfield JW; Fritsche KL; Wankhade UD; Chintapalli SV; Shankar K; Ibdah JA; Rector RS
Am J Physiol Endocrinol Metab; 2018 Jan; 314(1):E78-E92. PubMed ID: 28899857
[TBL] [Abstract][Full Text] [Related]
10. Experimental non-alcoholic steatohepatitis in Göttingen Minipigs: consequences of high fat-fructose-cholesterol diet and diabetes.
Schumacher-Petersen C; Christoffersen BØ; Kirk RK; Ludvigsen TP; Zois NE; Pedersen HD; Vyberg M; Olsen LH
J Transl Med; 2019 Apr; 17(1):110. PubMed ID: 30943987
[TBL] [Abstract][Full Text] [Related]
11. Progression of non-alcoholic steatosis to steatohepatitis and fibrosis parallels cumulative accumulation of danger signals that promote inflammation and liver tumors in a high fat-cholesterol-sugar diet model in mice.
Ganz M; Bukong TN; Csak T; Saha B; Park JK; Ambade A; Kodys K; Szabo G
J Transl Med; 2015 Jun; 13():193. PubMed ID: 26077675
[TBL] [Abstract][Full Text] [Related]
12. SIRT3 Deficiency Promotes High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease in Correlation with Impaired Intestinal Permeability through Gut Microbial Dysbiosis.
Chen M; Hui S; Lang H; Zhou M; Zhang Y; Kang C; Zeng X; Zhang Q; Yi L; Mi M
Mol Nutr Food Res; 2019 Feb; 63(4):e1800612. PubMed ID: 30525304
[TBL] [Abstract][Full Text] [Related]
13. Lactobacillus pentosus strain S-PT84 improves steatohepatitis by maintaining gut permeability.
Sakai Y; Arie H; Ni Y; Zhuge F; Xu L; Chen G; Nagata N; Suzuki T; Kaneko S; Ota T; Nagashimada M
J Endocrinol; 2020 Nov; 247(2):169-181. PubMed ID: 33032263
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of Methionine Content in a High-Fat and Choline-Deficient Diet on Body Weight Gain and the Development of Non-Alcoholic Steatohepatitis in Mice.
Chiba T; Suzuki S; Sato Y; Itoh T; Umegaki K
PLoS One; 2016; 11(10):e0164191. PubMed ID: 27723801
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-17 Weakens the NAFLD/NASH Process by Facilitating Intestinal Barrier Restoration Depending on the Gut Microbiota.
He S; Cui S; Song W; Jiang Y; Chen H; Liao D; Lu X; Li J; Chen X; Peng L
mBio; 2022 Apr; 13(2):e0368821. PubMed ID: 35266816
[TBL] [Abstract][Full Text] [Related]
16. Ileal Bile Acid Transporter Inhibitor Improves Hepatic Steatosis by Ameliorating Gut Microbiota Dysbiosis in NAFLD Model Mice.
Matsui M; Fukunishi S; Nakano T; Ueno T; Higuchi K; Asai A
mBio; 2021 Aug; 12(4):e0115521. PubMed ID: 34225483
[TBL] [Abstract][Full Text] [Related]
17. Magnesium isoglycyrrhizinate attenuates nonalcoholic fatty liver disease by strengthening intestinal mucosal barrier.
Lai X; Zhou H; Wan Y; Kuang J; Yang Y; Mai L; Chen Y; Liu B
Int Immunopharmacol; 2024 Feb; 128():111429. PubMed ID: 38171057
[TBL] [Abstract][Full Text] [Related]
18. Compromised intestinal epithelial barrier induces adaptive immune compensation that protects from colitis.
Khounlotham M; Kim W; Peatman E; Nava P; Medina-Contreras O; Addis C; Koch S; Fournier B; Nusrat A; Denning TL; Parkos CA
Immunity; 2012 Sep; 37(3):563-73. PubMed ID: 22981539
[TBL] [Abstract][Full Text] [Related]
19. Dysregulated FXR-FGF19 signaling and choline metabolism are associated with gut dysbiosis and hyperplasia in a novel pig model of pediatric NASH.
Hernandez GV; Smith VA; Melnyk M; Burd MA; Sprayberry KA; Edwards MS; Peterson DG; Bennet DC; Fanter RK; Columbus DA; Steibel JP; Glanz H; Immoos C; Rice MS; Santiago-Rodriguez TM; Blank J; VanderKelen JJ; Kitts CL; Piccolo BD; La Frano MR; Burrin DG; Maj M; Manjarin R
Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G582-G609. PubMed ID: 32003601
[TBL] [Abstract][Full Text] [Related]
20. Dietary cholesterol drives fatty liver-associated liver cancer by modulating gut microbiota and metabolites.
Zhang X; Coker OO; Chu ES; Fu K; Lau HCH; Wang YX; Chan AWH; Wei H; Yang X; Sung JJY; Yu J
Gut; 2021 Apr; 70(4):761-774. PubMed ID: 32694178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
